200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 7414-83-7
7414-83-7 | Disodium Etidronate Hydrate
CAS No: 7414-83-7 Catalog No: AG003PRC MDL No:MFCD00152567
Product Description
Catalog Number:
AG003PRC
Chemical Name:
Disodium Etidronate Hydrate
CAS Number:
7414-83-7
Molecular Formula:
C2H6Na2O7P2
Molecular Weight:
249.9919
MDL Number:
MFCD00152567
IUPAC Name:
disodium;hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]ethyl]phosphinate
InChI:
InChI=1S/C2H8O7P2.2Na/c1-2(3,10(4,5)6)11(7,8)9;;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);;/q;2*+1/p-2
InChI Key:
GWBBVOVXJZATQQ-UHFFFAOYSA-L
SMILES:
CC(P(=O)(O)[O-])(P(=O)(O)[O-])O.[Na+].[Na+]
EC Number:
231-025-7
UNII:
M16PXG993G
Properties
Complexity:
206
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
249.938g/mol
Formal Charge:
0
Heavy Atom Count:
13
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
249.99g/mol
Monoisotopic Mass:
249.938g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
141A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). | European journal of cancer (Oxford, England : 1990) 20121101 |
| Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. | Spine 20121101 |
| Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20121001 |
| Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial. | Journal of cancer research and clinical oncology 20120901 |
| Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates. | Journal of bone and mineral metabolism 20120901 |
| Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study. | Bone 20120901 |
| Risedronate-associated scleritis: a case report and review of the literature. | Clinical rheumatology 20120901 |
| Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3. | Progress in transplantation (Aliso Viejo, Calif.) 20120901 |
| Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| The association between automatic generic substitution and treatment persistence with oral bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| The effect of etidronate on the periodontium of ovariectomized rats. | Journal of periodontology 20120801 |
| Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. | Journal of Crohn's & colitis 20120801 |
| Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120801 |
| Lipid profiles within the SABRE trial of anastrozole with and without risedronate. | Breast cancer research and treatment 20120801 |
| Effect of risedronate on bone in renal transplant recipients. | Journal of the American Society of Nephrology : JASN 20120801 |
| Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate. | Morphologie : bulletin de l'Association des anatomistes 20120801 |
| Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer. | Journal of bone and mineral metabolism 20120701 |
| Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism. | Journal of Crohn's & colitis 20120701 |
| Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? | The Journal of bone and joint surgery. British volume 20120701 |
| Bisphosphonates in multiple myeloma: a network meta-analysis. | The Cochrane database of systematic reviews 20120516 |
| Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514 |
| Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies. | Rheumatology international 20120501 |
| Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis. | Current medical research and opinion 20120501 |
| Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501 |
| Reduction of hard-tissue debris accumulation during rotary root canal instrumentation by etidronic acid in a sodium hypochlorite irrigant. | Journal of endodontics 20120501 |
| Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis. | Rheumatology international 20120401 |
| Effects of etidronate on calcification of scales and ribs in the goldfish, Carassius auratus. | Fish physiology and biochemistry 20120401 |
| Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120401 |
| Potential genotoxic effect of 186Re-HEDP on human lymphocyte cells: in-vitro evaluation with micronucleus-FISH analysis. | Nuclear medicine communications 20120401 |
| [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection]. | Se pu = Chinese journal of chromatography 20120401 |
| Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity. | Proceedings of the National Academy of Sciences of the United States of America 20120313 |
| Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308 |
| Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. | Rheumatology international 20120301 |
| Adherence to osteoporosis medications amongst Singaporean patients. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Esophageal and gastric cancer incidence and mortality in alendronate users. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120301 |
| Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). | Current medical research and opinion 20120301 |
| Paget disease of bone - an update. | Australian family physician 20120301 |
| Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy. | The Journal of oral implantology 20120201 |
| Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201 |
| Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201 |
| Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA. | Clinical drug investigation 20120201 |
| Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115 |
| Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. | Journal of bone and mineral metabolism 20120101 |
| Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model. | Bone 20120101 |
| Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. | Bone 20120101 |
| Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? | Calcified tissue international 20120101 |
| Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101 |
| Heel ultrasound can assess maintenance of bone mass in women with breast cancer. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101 |
| Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. | PloS one 20120101 |
| Femoral fractures in osteoporotic patients on bisphosphonates. A case report. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101 |
| [The use of light-emitting diode photomatrix red-light irradiation in patients with cervical dorsopathy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101 |
| Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. | Biological & pharmaceutical bulletin 20120101 |
| H2O2/UV-C treatment of textile preparation wastewater: kinetic investigation on alternative combinations of commercial textile preparation auxiliaries. | Environmental technology 20120101 |
| Atypical bilateral pedicle fracture in long-term bisphosphonate therapy. | Spine 20111215 |
| Orthopaedics: Structural support. | Nature 20111214 |
| Bisphosphonates for osteoporosis in primary biliary cirrhosis. | The Cochrane database of systematic reviews 20111207 |
| Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20111201 |
| The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111201 |
| Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial. | Journal of neurology, neurosurgery, and psychiatry 20111201 |
| Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201 |
| Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate. | Bone 20111201 |
| Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis. | Arthritis and rheumatism 20111201 |
| Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis. | Arthritis care & research 20111201 |
| Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. | European journal of pediatrics 20111201 |
| Effects of chelating agents on the mineral content of root canal dentin. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20111201 |
| Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201 |
| Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111201 |
| A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial). | European journal of nuclear medicine and molecular imaging 20111101 |
| Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101 |
| Effect of stopping risedronate after long-term treatment on bone turnover. | The Journal of clinical endocrinology and metabolism 20111101 |
| Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease. | European journal of gastroenterology & hepatology 20111101 |
| Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20111101 |
| Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. | International journal of pharmaceutics 20111031 |
| The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. | The Journal of bone and joint surgery. American volume 20111019 |
| Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover. | Bone 20111001 |
| Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. | Journal of clinical pharmacy and therapeutics 20111001 |
| Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost. | Journal of managed care pharmacy : JMCP 20111001 |
| Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. | Journal of bone and mineral metabolism 20110901 |
| Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study. | Prostate cancer and prostatic diseases 20110901 |
| Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. | Journal of bone and mineral metabolism 20110901 |
| Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA). | Calcified tissue international 20110901 |
| In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada. | Current medical research and opinion 20110901 |
| What is the optimal duration of bisphosphonate therapy? | Cleveland Clinic journal of medicine 20110901 |
| Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells. | Basic & clinical pharmacology & toxicology 20110801 |
| Radionuclide therapy and integrated protocols for bone metastases. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20110801 |
| Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate. | Bone 20110701 |
| Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis. | Journal of bone and mineral metabolism 20110701 |
| Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110701 |
| Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. | Transplant international : official journal of the European Society for Organ Transplantation 20110701 |
| Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice. | Bone 20110701 |
| Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. | The Journal of clinical endocrinology and metabolism 20110701 |
| Simultaneous bilateral subtrochanteric fractures following risedronate therapy. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110701 |
| Shotgun proteomics analysis reveals new unsuspected molecular effectors of nitrogen-containing bisphosphonates in osteocytes. | Journal of proteomics 20110610 |
| Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. | Calcified tissue international 20110601 |
| Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis. | Clinical endocrinology 20110601 |
| Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | Panminerva medica 20110601 |
| Crystallization products of risedronate with carbohydrates and their substituted derivatives. | Molecules (Basel, Switzerland) 20110504 |
| Effects of risedronate on bone marrow adipocytes in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501 |
| In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. | Antimicrobial agents and chemotherapy 20110501 |
| MOVAS-1 cell line: a new in vitro model of vascular calcification. | International journal of molecular medicine 20110501 |
| Dose-dependent differential effects of risedronate on gene expression in osteoblasts. | Biochemical pharmacology 20110415 |
| Stroke in relation to use of raloxifene and other drugs against osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110401 |
| Osteoporosis medication and reduced mortality risk in elderly women and men. | The Journal of clinical endocrinology and metabolism 20110401 |
| The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases. | Cancer biotherapy & radiopharmaceuticals 20110401 |
| In brief: delayed-release risedronate (Atelvia). | The Medical letter on drugs and therapeutics 20110321 |
| Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy. | Clinical and experimental dermatology 20110301 |
| Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301 |
| Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301 |
| Characterization of a new solvate of risedronate. | Journal of pharmaceutical sciences 20110301 |
| Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats. | American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20110301 |
| Osteonecrosis of the jaw and the role of macrophages. | Journal of the National Cancer Institute 20110202 |
| [Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain]. | Atencion primaria 20110201 |
| A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres. | Journal of pharmaceutical sciences 20110201 |
| Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. | Bone 20110201 |
| Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20110201 |
| Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases. | Acta orthopaedica 20110201 |
| Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110201 |
| Treatments for osteoporosis in people with a disability. | PM & R : the journal of injury, function, and rehabilitation 20110201 |
| Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study. | Journal of bone and mineral metabolism 20110101 |
| Bedside ultrasound in early diagnosis of neurogenic heterotopic ossification in patients with acquired brain injury. | Clinical neurology and neurosurgery 20110101 |
| Calciphylaxis in POEMS syndrome: A case treated with etidronate. | Acta dermato-venereologica 20110101 |
| The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. | Breast cancer research and treatment 20110101 |
| When do bisphosphonates make the most sense? | The Journal of family practice 20110101 |
| A case of Marinesco-Sjögren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate. | Internal medicine (Tokyo, Japan) 20110101 |
| Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging. | Journal of atherosclerosis and thrombosis 20110101 |
| [Bilateral pathological sub-trochanteric fracture in a long-term biphosphonate user]. | Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20110101 |
| Fracture prevention in postmenopausal women. | BMJ clinical evidence 20110101 |
| Multiple vertebral compression fractures associated with post partum osteoporosis. | Journal of back and musculoskeletal rehabilitation 20110101 |
| The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101 |
| The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. | The Kurume medical journal 20110101 |
| Stress fractures: diagnosis, treatment, and prevention. | American family physician 20110101 |
| Going on a drug holiday? | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101 |
| Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study. | Life sciences 20101218 |
| Risedronate metal complexes potentially active against Chagas disease. | Journal of inorganic biochemistry 20101201 |
| The effects of topical application of bisphosphonates on replanted rat molars. | Dental traumatology : official publication of International Association for Dental Traumatology 20101201 |
| Response of postpoliomyelitis patients to bisphosphonate treatment. | PM & R : the journal of injury, function, and rehabilitation 20101201 |
| Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System. | Clinical breast cancer 20101201 |
| [Comparative analysis of dimephosphon, ionol, and xydiphone effects on indomethacin-induced gastric lesions in rats]. | Eksperimental'naia i klinicheskaia farmakologiia 20101201 |
| Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. | BJU international 20101101 |
| Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101101 |
| Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women. | Calcified tissue international 20101101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| [Positioning of bisphosphonates for vascular calcification]. | Clinical calcium 20101101 |
| How to prevent glucocorticoid-induced osteoporosis. | Cleveland Clinic journal of medicine 20101101 |
| The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation. | Spine 20101015 |
| Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101009 |
| Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase. | Bioorganic & medicinal chemistry letters 20101001 |
| Risk of upper gastrointestinal tract events in risedronate users switched to alendronate. | Calcified tissue international 20101001 |
| Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT. | International journal of rheumatic diseases 20101001 |
| High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. | Journal of bone and mineral metabolism 20100901 |
| In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. | Arthritis and rheumatism 20100901 |
| [Dementia and fracture]. | Clinical calcium 20100901 |
| [Jaw osteonecrosis induced by oral biphosphonates: 12 cases]. | Revue de stomatologie et de chirurgie maxillo-faciale 20100901 |
| The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801 |
| Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack. | Acta orthopaedica 20100801 |
| Effect of risedronate on bone resorption during consolidation phase of distraction osteogenesis: a rabbit model. | Journal of orthopaedic surgery (Hong Kong) 20100801 |
| Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice. | Journal of bone and mineral metabolism 20100701 |
| Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone. | Journal of bone and mineral metabolism 20100701 |
| How do bisphosphonates inhibit bone metastasis in vivo? | Neoplasia (New York, N.Y.) 20100701 |
| [Osteoporosis management in general practice. Preventing spontaneous bone fractures]. | MMW Fortschritte der Medizin 20100701 |
| Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients. | Transplantation 20100627 |
| Longitudinal change in clinical fracture incidence after initiation of bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601 |
| Birefringence of the secretory-stage enamel organic extracellular matrix from rats submitted to successive injections of bisphosphonates. | Connective tissue research 20100601 |
| Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis. | The American journal of the medical sciences 20100601 |
| Risedronate-induced arthritis. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601 |
| Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin? | Journal of musculoskeletal & neuronal interactions 20100601 |
| Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid. | Journal of medicinal chemistry 20100513 |
| Atypical femoral fractures and bisphosphonate use. | The New England journal of medicine 20100513 |
| WITHDRAWN: Pharmacological interventions for treating acute heterotopic ossification. | The Cochrane database of systematic reviews 20100512 |
| An in vitro assay to measure targeted drug delivery to bone mineral. | ChemMedChem 20100503 |
| Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501 |
| Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study. | Calcified tissue international 20100501 |
| Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis. | Pediatric pulmonology 20100501 |
| Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20100501 |
| How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care. | Journal of the American Dental Association (1939) 20100501 |
| Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401 |
| Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis. | Aging clinical and experimental research 20100401 |
| Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies. | Journal of the American Geriatrics Society 20100401 |
| Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100301 |
| Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301 |
| The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301 |
| The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial. | Bone 20100301 |
| Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. | Bone 20100301 |
| Heterotopic ossification in the residual lower limb in an adult nontraumatic amputee patient. | American journal of physical medicine & rehabilitation 20100301 |
| Effect of osteoporosis treatment on mortality: a meta-analysis. | The Journal of clinical endocrinology and metabolism 20100301 |
| Response to oral bisphosphonates in subgroups of younger and older postmenopausal women. | Journal of women's health (2002) 20100301 |
| Effects of risedronate on osteoarthritis of the knee. | Yonsei medical journal 20100301 |
| [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient]. | Ugeskrift for laeger 20100301 |
| Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301 |
| Intravenous zoledronic acid: what are the indications for male osteoporosis? | Current osteoporosis reports 20100301 |
| Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| Unusual mid-shaft fractures during long-term bisphosphonate therapy. | Clinical endocrinology 20100201 |
| Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. | Bone 20100201 |
| Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201 |
| Gastric and esophagus events before and during treatment of osteoporosis. | Calcified tissue international 20100201 |
| Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100201 |
| A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101 |
| Risedronate reduces intracortical porosity in women with osteoporosis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101 |
| Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. | Journal of bone and mineral metabolism 20100101 |
| Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations. | Bone 20100101 |
| Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body. | Bone 20100101 |
| Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading. | Bone 20100101 |
| Differences between bisphosphonates in binding affinities for hydroxyapatite. | Journal of biomedical materials research. Part B, Applied biomaterials 20100101 |
| Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101 |
| Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. | Calcified tissue international 20100101 |
| [Diagnosis and treatment of osteoporosis in persons aged more than 75 years]. | Revista espanola de geriatria y gerontologia 20100101 |
| Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. | Internal medicine (Tokyo, Japan) 20100101 |
| Analysis of risedronate and related substances by ion-pair reversed-phase high-performance liquid chromatography with evaporative light-scattering detection. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101 |
| Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. | Breast cancer research : BCR 20100101 |
| Challenges in clinical patient management. | Cancer investigation 20100101 |
| The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation. | Arthritis research & therapy 20100101 |
| Development of an ion-pair reversed-phase HPLC method with indirect UV detection for determination of phosphates and phosphites as impurities in sodium risedronate. | Journal of AOAC International 20100101 |
| Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies. | Journal of AOAC International 20100101 |
| Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome. | Internal medicine (Tokyo, Japan) 20100101 |
| Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. | General dentistry 20100101 |
| Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. | Rheumatology international 20091201 |
| Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. | Current medical research and opinion 20091201 |
| Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091201 |
| Review of osteoporosis pharmacotherapy for geriatric patients. | The American journal of geriatric pharmacotherapy 20091201 |
| Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101 |
| Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101 |
| Synthetic, structural and solution speciation studies on binary Al(III)-(carboxy)phosphonate systems. Relevance to the neurotoxic potential of Al(III). | Journal of inorganic biochemistry 20091101 |
| Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. | Calcified tissue international 20091101 |
| A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. | Journal of endodontics 20091101 |
| Comparative gastrointestinal safety of weekly oral bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001 |
| Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001 |
| Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. | The Journal of clinical endocrinology and metabolism 20091001 |
| Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention. | Biomaterials 20091001 |
| Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice. | Cancer biotherapy & radiopharmaceuticals 20091001 |
| Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901 |
| (188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study. | European journal of nuclear medicine and molecular imaging 20090901 |
| Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. | International journal of cancer 20090901 |
| Re 'Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors' by A. Luckish et al. | Bone 20090901 |
| Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer. | Nuclear medicine communications 20090901 |
| Differences in persistence among different weekly oral bisphosphonate medications. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801 |
| Intracanal bisphosphonate does not inhibit replacement resorption associated with delayed replantation of monkey incisors. | Dental traumatology : official publication of International Association for Dental Traumatology 20090801 |
| Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy. | Current medical research and opinion 20090801 |
| [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate]. | Clinical calcium 20090801 |
| Corticosteroids: no drug prevention of fractures needed. | Prescrire international 20090801 |
| Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment. | La Tunisie medicale 20090801 |
| Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. | Maturitas 20090720 |
| Rapid estimation of trace organophosphonate used as a scale inhibitor in aqueous systems by reactive pyrolysis-gas chromatography/mass spectrometry. | Journal of chromatography. A 20090703 |
| Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701 |
| Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. | Biological & pharmaceutical bulletin 20090701 |
| [Acute exacerbation of a chronic esophagitis]. | Deutsche medizinische Wochenschrift (1946) 20090701 |
| DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090601 |
| Bone microdamage. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy. | Urology 20090601 |
| Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601 |
| Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. | The Journal of pharmacy and pharmacology 20090601 |
| Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment. | La Tunisie medicale 20090601 |
| Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage. | Journal of biomechanics 20090511 |
| Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. | Bone 20090501 |
| Atrial fibrillation in fracture patients treated with oral bisphosphonates. | Journal of internal medicine 20090501 |
| Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates. | Southern medical journal 20090501 |
| Osteonecrosis associated with short-term oral administration of bisphosphonate. | The Journal of prosthetic dentistry 20090501 |
| [Etidronate for treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20090501 |
| [Risedronate for treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20090501 |
| Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy. | The Journal of the Michigan Dental Association 20090501 |
| Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study. | Yonsei medical journal 20090430 |
| Glucocorticoid-induced osteoporosis: hope on the HORIZON. | Lancet (London, England) 20090411 |
| Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. | Lancet (London, England) 20090411 |
| Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401 |
| Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone. | Bone 20090401 |
| Effects of ethylenediaminetetraacetic, etidronic and peracetic acid irrigation on human root dentine and the smear layer. | International endodontic journal 20090401 |
| Myositis ossificans: a case report of multiple recurrences following third molar extractions and review of the literature. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090401 |
| Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. | The Annals of pharmacotherapy 20090401 |
| Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. | The Journal of hand surgery 20090401 |
| [Postmenopausal osteoporosis. Bisphosphonates are not all equal]. | MMW Fortschritte der Medizin 20090312 |
| [Patient compliance program aids therapy success]. | MMW Fortschritte der Medizin 20090312 |
| Effect of risedronate in a minipig cartilage defect model with allograft. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090301 |
| Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301 |
| Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. | Kidney international 20090301 |
| LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men. | Calcified tissue international 20090301 |
| Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090301 |
| Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates. | Journal of proteome research 20090301 |
| Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. | Current osteoporosis reports 20090301 |
| Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? | Kidney international 20090301 |
| Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. | Brain research 20090219 |
| Vitamin D status and response to treatment in post-menopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201 |
| Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. | The American journal of medicine 20090201 |
| Monaural diplacusis with tinnitus, aural fullness, hyperacusis, and sensorineural hearing loss. | Ear, nose, & throat journal 20090201 |
| Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial. | Scottish medical journal 20090201 |
| Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. | Clinical therapeutics 20090201 |
| Paget's disease 2: exploring diagnosis, management and support strategies. | Nursing times 20090201 |
| Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101 |
| Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. | Rheumatology international 20090101 |
| The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. | QJM : monthly journal of the Association of Physicians 20090101 |
| Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101 |
| [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates]. | Clinical calcium 20090101 |
| Heterotopic ossification: pharmacologic options. | The Journal of head trauma rehabilitation 20090101 |
| New bisphosphonates and trends in drug therapy for osteoporosis: preface. | Clinical calcium 20090101 |
| [Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20090101 |
| Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study. | Journal of bone and mineral metabolism 20090101 |
| Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP. | Nuklearmedizin. Nuclear medicine 20090101 |
| Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. | Journal of bone and mineral metabolism 20090101 |
| Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. | PloS one 20090101 |
| The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study. | Journal of bone and mineral metabolism 20090101 |
| Heterotopic ossification in systemic sclerosis. | Scandinavian journal of rheumatology 20090101 |
| Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies. | Drugs & aging 20090101 |
| Anti-fracture efficacy of risedronic acid in men: A meta-analysis of randomized controlled trials. | Clinical drug investigation 20090101 |
| Risedronate on two consecutive days per month. | Drugs & aging 20090101 |
| Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. | Clinical interventions in aging 20090101 |
| The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. | BMC musculoskeletal disorders 20090101 |
| Risedronate inhibits human osteosarcoma cell invasion. | Journal of experimental & clinical cancer research : CR 20090101 |
| Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection. | Genome biology 20090101 |
| Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. | Internal medicine (Tokyo, Japan) 20090101 |
| Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease. | Aging clinical and experimental research 20090101 |
| Reducing hip fracture risk with risedronate in elderly women with established osteoporosis. | Clinical interventions in aging 20090101 |
| Evaluation of the effect of 4 months of risedronate therapy on femoral strength using femoral strength analysis tools. | The Journal of international medical research 20090101 |
| Geranylgeranyl transferase type II inhibition prevents myeloma bone disease. | Biochemical and biophysical research communications 20081212 |
| Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201 |
| A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues. | Journal of inorganic biochemistry 20081201 |
| [Non traumatic tooth extraction in patients treated by bisphosphonate]. | Revue de stomatologie et de chirurgie maxillo-faciale 20081201 |
| Fluorescently labeled risedronate and related analogues: 'magic linker' synthesis. | Bioconjugate chemistry 20081201 |
| Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible. | Dento maxillo facial radiology 20081201 |
| Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode. | International journal of pharmaceutics 20081119 |
| Compatibility of risedronate sodium tablets with food thickeners. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115 |
| Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats. | Orthodontics & craniofacial research 20081101 |
| Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. | Cancer research 20081101 |
| Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. | Arthritis and rheumatism 20081101 |
| Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies. | Micron (Oxford, England : 1993) 20081001 |
| Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001 |
| Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. | Bone 20081001 |
| Cutaneous vasculitis induced by risedronate. | Allergy 20081001 |
| [Efficacy and tolerability of risedronate for the treatment of osteoporosis]. | Clinical calcium 20081001 |
| [Evidence and utility of etidronate for the treatment of osteoporosis]. | Clinical calcium 20081001 |
| Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats. | Journal of periodontology 20081001 |
| Paget disease of bone: therapeutic options. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001 |
| [Treatment of osteoporosis in the elderly: what is the evidence?]. | Tijdschrift voor gerontologie en geriatrie 20081001 |
| Risedronic acid: new indication. No fewer symptomatic fractures in men. | Prescrire international 20081001 |
| [Severe oesophagus injury as a complication during treatment with risedronic acid]. | Nederlands tijdschrift voor geneeskunde 20080927 |
| Monthly risedronate (Actonel) for postmenopausal osteoporosis. | The Medical letter on drugs and therapeutics 20080908 |
| Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates. | Current osteoporosis reports 20080901 |
| IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. | Expert review of anticancer therapy 20080901 |
| Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. | The American journal of managed care 20080901 |
| Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080901 |
| Biomechanical analysis of combined treatment of high calcium and bisphosphonate in tibia of steroid-treated growing-phase rats. | Dental materials journal 20080901 |
| Phosphatase actions at the site of appositional mineralization in bisphosphonate-affected bones of the rat. | Journal of medical and dental sciences 20080901 |
| Osteoporosis in men. | The New England journal of medicine 20080821 |
| Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801 |
| Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors. | Bone 20080801 |
| Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women. | Bone 20080801 |
| Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. | Calcified tissue international 20080801 |
| Maximizing effectiveness of bisphosphonate therapy for osteoporosis. | Southern medical journal 20080801 |
| Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients. | Climacteric : the journal of the International Menopause Society 20080801 |
| Inhibition of the formation of oral calcium phosphate precipitates: the possible effects of certain honeybee products. | Journal of periodontal research 20080801 |
| Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs. | Journal of medicinal chemistry 20080724 |
| An ATR-FTIR study of different phosphonic acids in aqueous solution. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080701 |
| Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701 |
| 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. | European journal of nuclear medicine and molecular imaging 20080701 |
| Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases. | European journal of nuclear medicine and molecular imaging 20080701 |
| Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. | British journal of clinical pharmacology 20080701 |
| Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease. | Journal of medical virology 20080701 |
| Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats. | The Chinese journal of physiology 20080630 |
| Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. | Osteoarthritis and cartilage 20080601 |
| Matrix mineralization as a trigger for osteocyte maturation. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20080601 |
| Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. | International journal of clinical practice 20080601 |
| Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601 |
| Secondary osteoporosis in long-term bedridden patients with cerebral palsy. | Pediatrics international : official journal of the Japan Pediatric Society 20080601 |
| Risedronic acid and calcium + colecalciferol: new combination. A simple combination of two other products. A simple commercial ploy with no benefit for patients. | Prescrire international 20080601 |
| Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis. | Clinical interventions in aging 20080601 |
| Summaries for patients. Drug therapy for osteoporosis. | Annals of internal medicine 20080506 |
| Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. | Annals of internal medicine 20080506 |
| Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. | Annals of the rheumatic diseases 20080501 |
| The use of eidronate disodium in the prevention of heterotopic ossification in burn patients. | Burns : journal of the International Society for Burn Injuries 20080501 |
| Effects of risedronate on fracture risk in postmenopausal women with osteopenia. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501 |
| Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501 |
| Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. | Bone 20080501 |
| Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. | Current medical research and opinion 20080501 |
| Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. | Current medical research and opinion 20080501 |
| Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies. | Bioorganic & medicinal chemistry letters 20080501 |
| Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects. | Clinical therapeutics 20080501 |
| Can a disorder of the vestibular system underlie an etiology for migraine? | Ear, nose, & throat journal 20080501 |
| Osteoporotic fracture management in India: a survey of orthopaedic surgeons. | Journal of the Indian Medical Association 20080501 |
| Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080401 |
| A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International. | International journal of clinical practice 20080401 |
| In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications. | Current medical research and opinion 20080401 |
| Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080401 |
| Osteonecrosis of the jaw: new developments in an old disease. | The Journal of rheumatology 20080401 |
| Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080401 |
| Re-186 HEDP treatment in breast cancer patients with bone metastases. | Journal of the National Medical Association 20080401 |
| Direct stability-indicating method development and validation for analysis of etidronate disodium using a mixed-mode column and charged aerosol detector. | Journal of pharmaceutical and biomedical analysis 20080313 |
| Fracture risk remains reduced one year after discontinuation of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080301 |
| Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy. | Clinical biomechanics (Bristol, Avon) 20080301 |
| Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. | Current medical research and opinion 20080301 |
| Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. | The Journal of rheumatology 20080301 |
| [Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301 |
| [Osteonecrosis of the jaw developing during bisphosphonate treatment]. | Magyar onkologia 20080301 |
| [Radius shaft fracture in a 31-year old man]. | Revista clinica espanola 20080201 |
| NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model. | Journal of the American Chemical Society 20080130 |
| Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. | The Cochrane database of systematic reviews 20080123 |
| Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. | The Cochrane database of systematic reviews 20080123 |
| Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101 |
| Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. | Bone 20080101 |
| Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup. | The Journal of rheumatology 20080101 |
| The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis. | Journal of bone and mineral metabolism 20080101 |
| Longitudinal co-site optical microscopy study on the chelating ability of etidronate and EDTA using a comparative single-tooth model. | Journal of endodontics 20080101 |
| [Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients]. | Nihon rinsho. Japanese journal of clinical medicine 20080101 |
| Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women. | The Tohoku journal of experimental medicine 20080101 |
| [Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine]. | Revista clinica espanola 20080101 |
| [Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080101 |
| Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study. | Clinical drug investigation 20080101 |
| Phytate inhibits bovine pericardium calcification in vitro. | Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 20080101 |
| Efficacy of risedronate in Japanese male patients with primary osteoporosis. | Internal medicine (Tokyo, Japan) 20080101 |
| Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial. | Journal of bone and mineral metabolism 20080101 |
| Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats. | Hormone research 20080101 |
| Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. | Scandinavian journal of clinical and laboratory investigation 20080101 |
| Cytotoxicity of etidronic acid to human breast cancer cells. | Ethnicity & disease 20080101 |
| Application of UV-derivative spectrophotometry for determination of some bisphosphonates drugs in pharmaceutical formulations. | Acta poloniae pharmaceutica 20080101 |
| Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study. | Menopause (New York, N.Y.) 20080101 |
| Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines. | Anticancer research 20080101 |
| Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine. | The Journal of international medical research 20080101 |
| [Mechanisms of formation of chronic low back pain relapse and their correction in patients with dorsopathy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| [Antioxidant and peroxidase activity of saliva in patients with inflammatory periodontal diseases and ability of their correction]. | Biomeditsinskaia khimiia 20080101 |
| [Differences among bisfosfonates--specificity of risedronate (Actonel)]. | Reumatizam 20080101 |
| Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. | BMC musculoskeletal disorders 20080101 |
| Medical treatment of otosclerosis: rationale for use of bisphosphonates. | The international tinnitus journal 20080101 |
| Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective. | Journal of medical economics 20080101 |
| Importance of negative trials. | Inflammatory bowel diseases 20071201 |
| Hip fractures in users of first- vs. second-generation bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071201 |
| Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study. | Current medical research and opinion 20071201 |
| Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. | Journal of the American Academy of Dermatology 20071201 |
| Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071201 |
| Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer. | International journal of urology : official journal of the Japanese Urological Association 20071201 |
| Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures. | Minerva endocrinologica 20071201 |
| What is new in the treatment of steroid-induced osteoporosis? | Seminars in cutaneous medicine and surgery 20071201 |
| Etidronate: what is its place in treatment of primary osteoporosis and other demineralizing diseases today? | Current osteoporosis reports 20071201 |
| Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate. | Journal of medicinal chemistry 20071129 |
| [HIP study--how to prevent hip fractures?]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [FACT study]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Bisphosphonates for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Evidence of risedronate for treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| Risedronate did not block the maximal anabolic effect of PTH in aged rats. | Bone 20071101 |
| Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. | Current medical research and opinion 20071101 |
| Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7. | Oncology reports 20071101 |
| Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071101 |
| Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate. | Expert opinion on pharmacotherapy 20071101 |
| The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. | Arthritis and rheumatism 20071101 |
| [Concurrent treatment of osteoporosis including vitamin K]. | Clinical calcium 20071101 |
| [Paget's disease of bone]. | Clinical calcium 20071101 |
| Effect of etidronate on COX-2 expression and PGE(2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20071101 |
| Osteoporosis--from hormonal replacement therapy to bisphosphonates and beyond: a review. | East African medical journal 20071101 |
| Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001 |
| Modeling and spectroscopic studies of bisphosphonate-bone interactions. The Raman, NMR and crystallographic investigations of Ca-HEDP complexes. | Bone 20071001 |
| Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients. | The journal of obstetrics and gynaecology research 20071001 |
| Osteoporosis: non-hormonal treatment. | Climacteric : the journal of the International Menopause Society 20071001 |
| [Drug-induced osteomalacia]. | Clinical calcium 20071001 |
| [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug]. | Clinical calcium 20071001 |
| Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. | Journal of endocrinological investigation 20071001 |
| Rhenium-186 hydroxyethylidenediphosphonate (186Re HEDP) for the treatment of hemophilic arthropathy: first results. | The Clinical journal of pain 20070901 |
| Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. | Journal of periodontology 20070901 |
| Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070901 |
| Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. | Clinical therapeutics 20070901 |
| Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. | Clinical interventions in aging 20070901 |
| Fracture prevention in postmenopausal women. | BMJ clinical evidence 20070901 |
| Yearly zoledronic acid in postmenopausal osteoporosis. | The New England journal of medicine 20070816 |
| Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine. | Journal of chromatography. A 20070810 |
| Weekly risedronate in kidney transplant patients with osteopenia. | Transplant international : official journal of the European Society for Organ Transplantation 20070801 |
| Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. | Calcified tissue international 20070801 |
| A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. | Nuclear medicine communications 20070801 |
| Clinical management of a patient with a 12-year history of a balance disorder. | Ear, nose, & throat journal 20070801 |
| Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. | British dental journal 20070728 |
| WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20070718 |
| WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20070718 |
| Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation. | European journal of nuclear medicine and molecular imaging 20070701 |
| Is cortical bone hip? What determines cortical bone properties? | Bone 20070701 |
| Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070701 |
| Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats. | Circulation journal : official journal of the Japanese Circulation Society 20070701 |
| Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases. | Anti-cancer agents in medicinal chemistry 20070701 |
| Increased uptake of technetium-99m HDP in the subcortical area of both femurs in a patient with Graves' disease. | Thyroid : official journal of the American Thyroid Association 20070701 |
| [Osteoporosis treatment: choices and options]. | Polskie Archiwum Medycyny Wewnetrznej 20070701 |
| Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601 |
| Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601 |
| Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070601 |
| Pharmacological treatment of osteoporosis for people over 70. | Aging clinical and experimental research 20070601 |
| The futility of current approaches to chondroprotection. | Arthritis and rheumatism 20070501 |
| Bisphosphonates. A cornerstone of osteoporosis treatment. | Mayo Clinic women's healthsource 20070501 |
| Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease. | Connecticut medicine 20070501 |
| Complexation of UVI with 1-hydroxyethane-1,1-diphosphonic acid in acidic to basic solutions. | Inorganic chemistry 20070402 |
| Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. | Bone 20070401 |
| Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. | The Journal of clinical endocrinology and metabolism 20070401 |
| [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis]. | Clinical calcium 20070401 |
| Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats. | Experimental animals 20070401 |
| [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice]. | MMW Fortschritte der Medizin 20070329 |
| Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. | Neurology 20070320 |
| Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal. | Journal of controlled release : official journal of the Controlled Release Society 20070312 |
| Risedronate for the prevention of hip fractures: concern about validity of trials. | Archives of internal medicine 20070312 |
| Prevention of aortic calcification by etidronate in the renal failure rat model. | European journal of pharmacology 20070308 |
| Prevention and treatment of glucocorticoid-induced osteoporosis. | Current osteoporosis reports 20070301 |
| Impact of lubricant parameters on rotary instrument torque and force. | Journal of endodontics 20070301 |
| Risedronate-induced Hepatitis. | The American journal of medicine 20070301 |
| Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. | The American journal of medicine 20070301 |
| Osteochemonecrosis of jaws and bisphosphonates. | Irish medical journal 20070301 |
| Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. | Analytica chimica acta 20070212 |
| Differential effects of bisphosphonates on breast cancer cell lines. | Cancer letters 20070208 |
| A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. | Rheumatology (Oxford, England) 20070201 |
| Evaluating SPIO-labelled cell MR efficiency by three-dimensional quantitative T2* MRI. | NMR in biomedicine 20070201 |
| [Etidronate per os in subcutaneous fat necrosis with hypercalcemia and nephrocalcinosis]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20070201 |
| Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. | Archives of medical research 20070201 |
| Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used. | Cancer biotherapy & radiopharmaceuticals 20070201 |
| Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101 |
| Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. | The Journal of clinical endocrinology and metabolism 20070101 |
| Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101 |
| How long should patients take medications for postmenopausal osteoporosis? | Joint, bone, spine : revue du rhumatisme 20070101 |
| The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20070101 |
| Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women. | Journal of bone and mineral metabolism 20070101 |
| Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol. | Journal of bone and mineral metabolism 20070101 |
| A case of blue rubber bleb nevus syndrome treated by etidronate. | Journal of bone and mineral metabolism 20070101 |
| Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate. | Journal of bone and mineral metabolism 20070101 |
| [The effect of risedronate treatment on bone turnover markers in patients with hip fracture]. | Acta orthopaedica et traumatologica turcica 20070101 |
| The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. | Renal failure 20070101 |
| Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy. | Clinical and experimental rheumatology 20070101 |
| Bisphosphonates and osteonecrosis of the jaw: a retrospective study. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. | Journal of musculoskeletal & neuronal interactions 20070101 |
| A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy. | Modern rheumatology 20070101 |
| Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. | Journal of bone and mineral metabolism 20070101 |
| Risedronate has no adverse effects on mouse haematopoiesis. | Folia biologica 20070101 |
| Safety considerations with bisphosphonates for the treatment of osteoporosis. | Drug safety 20070101 |
| Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. | Hormones (Athens, Greece) 20070101 |
| Etidronate for the treatment of progressive tumoral calcinosis in hemodialysis patients. | Internal medicine (Tokyo, Japan) 20070101 |
| [Application of xidiphone in complex of measures for inflammatory periodontal disease prevention]. | Stomatologiia 20070101 |
| High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman. | Wiener medizinische Wochenschrift (1946) 20070101 |
| Risedronate induced transient ocular myasthenia. | Journal of postgraduate medicine 20070101 |
| Effect of bisphosphonates on nitric oxide production by inflammatory activated chondrocytes. | Clinical and experimental rheumatology 20070101 |
| [On efficiency of local xidiphone in treating osteoporotic changes in hands of vibration disease patients]. | Meditsina truda i promyshlennaia ekologiia 20070101 |
| [Risedronate (Actonel)--from randomized clinical trials to real life]. | Reumatizam 20070101 |
| Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization. | Journal of pharmaceutical sciences 20061201 |
| [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20061201 |
| 186Re-HEDP in the treatment of patients with inoperable osteosarcoma. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20061201 |
| European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency. | Current medical research and opinion 20061201 |
| Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate. | Current medical research and opinion 20061201 |
| Bisphosphonates. | Annals of the New York Academy of Sciences 20061201 |
| Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. | Journal of nutritional science and vitaminology 20061201 |
| [Men also need bone protection]. | MMW Fortschritte der Medizin 20061116 |
| [Correlation between studies and general practice]. | MMW Fortschritte der Medizin 20061116 |
| RETRACTED: Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial. | Bone 20061101 |
| Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease. | Bone 20061101 |
| Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. | Bone 20061101 |
| Effect of temporal subtraction technique on interpretation time and diagnostic accuracy of chest radiography. | AJR. American journal of roentgenology 20061101 |
| Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. | Arthritis and rheumatism 20061101 |
| [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis]. | Clinical calcium 20061101 |
| Synthesis of bisphosphonate derivatives of ATP by T4 RNA ligase. | FEBS letters 20061016 |
| Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. | Pharmacoepidemiology and drug safety 20061001 |
| Is the increase in osteoporosis prevention a result of the audit? | Clinical neurology and neurosurgery 20061001 |
| Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines. | Bone 20061001 |
| Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. | Bone 20061001 |
| Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. | Bone 20061001 |
| Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001 |
| Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001 |
| Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20061001 |
| [Management of corticosteroid-induced osteoporosis]. | Presse medicale (Paris, France : 1983) 20061001 |
| Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. | Calcified tissue international 20061001 |
| Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats. | Experimental animals 20061001 |
| Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. | Journal of nutritional science and vitaminology 20061001 |
| [A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease']. | Nederlands tijdschrift voor geneeskunde 20060930 |
| Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation. | Biochemical and biophysical research communications 20060922 |
| Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells. | International journal of cancer 20060915 |
| A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. | European journal of nuclear medicine and molecular imaging 20060901 |
| Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats. | Bone 20060901 |
| Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. | Bone 20060901 |
| [Therapeutic effects of risedronate on Paget's disease of bone]. | Clinical calcium 20060901 |
| Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. | Bone 20060801 |
| Chemical makeup of microdamaged bone differs from undamaged bone. | Bone 20060801 |
| Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K+ channels. | Neuropharmacology 20060801 |
| Madarosis from mitochondriopathy. | Acta ophthalmologica Scandinavica 20060801 |
| Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. | The Journal of clinical endocrinology and metabolism 20060701 |
| Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice. | Clinical and experimental pharmacology & physiology 20060701 |
| Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060701 |
| Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060701 |
| Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. | Current medical research and opinion 20060701 |
| Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to risedronate. | Eukaryotic cell 20060701 |
| Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol. | Experimental animals 20060701 |
| Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. | Experimental animals 20060701 |
| [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly]. | MMW Fortschritte der Medizin 20060622 |
| Long-term experience with alendronate in the treatment of osteoporosis. | Expert opinion on pharmacotherapy 20060601 |
| Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting. | Southern medical journal 20060601 |
| Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy. | Leprosy review 20060601 |
| Fracture prevention in postmenopausal women. | Clinical evidence 20060601 |
| The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. | Proceedings of the National Academy of Sciences of the United States of America 20060516 |
| Adsorption of Me(II), HEDP, and Me(II)-HEDP onto boehmite at nonstoichiometric Me(II)-HEDP concentrations. | Environmental science & technology 20060515 |
| [Only bone densitometry answers this question. How stable are your patients' bones?]. | MMW Fortschritte der Medizin 20060504 |
| Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. | Rheumatology international 20060501 |
| Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060501 |
| Between-meal risedronate does not alter bone turnover in nursing home residents. | Journal of the American Geriatrics Society 20060501 |
| Osteoporosis in older people: a tale of two studies (and three treatments). | Journal of the American Geriatrics Society 20060501 |
| Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. | Current medical research and opinion 20060501 |
| [Atypical crowned dens syndrome]. | Presse medicale (Paris, France : 1983) 20060501 |
| Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. | Maturitas 20060420 |
| Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. | Journal of the neurological sciences 20060415 |
| Preventing osteoporosis-related fractures: an overview. | The American journal of medicine 20060401 |
| Subcutaneous fat necrosis with hypercalcemia. | Indian pediatrics 20060401 |
| Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis. | Climacteric : the journal of the International Menopause Society 20060401 |
| Drug insight: Bisphosphonates for postmenopausal osteoporosis. | Nature clinical practice. Endocrinology & metabolism 20060401 |
| Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease? | Nature clinical practice. Rheumatology 20060401 |
| Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis. | International journal of pharmaceutics 20060327 |
| Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase. | Journal of the American Chemical Society 20060322 |
| Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. | Rheumatology international 20060301 |
| Osteoporosis drug may protect joints. | Health news (Waltham, Mass.) 20060301 |
| Osteoporosis management in a Medicaid population after the Women's Health Initiative study. | Journal of women's health (2002) 20060301 |
| Potential adverse effects. | British dental journal 20060211 |
| Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201 |
| Hospitalization-related bone loss and the protective effect of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201 |
| Pharmacological therapy of Paget's and other metabolic bone diseases. | Bone 20060201 |
| Patients with hip fracture: what can be improved? | Bone 20060201 |
| Strategies for the prevention and treatment of osteoporosis during early postmenopause. | American journal of obstetrics and gynecology 20060201 |
| [Application of anti-resorptive drugs for the treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20060201 |
| Meningeal involvement in Wegener's granulomatosis. | The Journal of rheumatology 20060201 |
| Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. | Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20060201 |
| Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia. | Journal of nutritional science and vitaminology 20060201 |
| Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. | Clinical therapeutics 20060201 |
| Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis. | Rheumatology international 20060101 |
| The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. | The International journal of eating disorders 20060101 |
| Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design. | Proteins 20060101 |
| A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. | The American journal of gastroenterology 20060101 |
| Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England. | Drug safety 20060101 |
| Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease. | Journal of bone and mineral metabolism 20060101 |
| [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?]. | La Revue du praticien 20060101 |
| Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. | Transplantation proceedings 20060101 |
| [A head-to-head comparative study for evaluation of effectiveness among drugs for osteoporosis]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20060101 |
| Drug injury in the upper gastrointestinal tract: effects of alendronate. | Gastrointestinal endoscopy clinics of North America 20060101 |
| Challenges of recruitment of breast cancer survivors to a randomized clinical trial for osteoporosis prevention. | Cancer nursing 20060101 |
| The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study. | Acta orthopaedica Belgica 20060101 |
| Pseudogout attack induced during etidronate disodium therapy. | Modern rheumatology 20060101 |
| Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: a randomized, double blind, controlled trial. | Wiener klinische Wochenschrift 20060101 |
| Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer. | Urologia internationalis 20060101 |
| Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187. | Methods and findings in experimental and clinical pharmacology 20060101 |
| Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. | Drugs & aging 20060101 |
| Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. | Journal of bone and mineral metabolism 20060101 |
| Medication persistence with weekly versus daily doses of orally administered bisphosphonates. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101 |
| A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20060101 |
| Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy. | Journal of bone and mineral metabolism 20060101 |
| [Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature]. | Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20060101 |
| Comparative therapeutic use of Risedronate and Calcarea phosphorica--allopathy versus homeopathy--in bone repair in castrated rats. | Brazilian oral research 20060101 |
| Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease. | Drug safety 20060101 |
| Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international. | Clinical drug investigation 20060101 |
| Effect of etidronic acid on arterial calcification in dialysis patients. | Clinical drug investigation 20060101 |
| Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. | Modern rheumatology 20060101 |
| Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis. | Advances in therapy 20060101 |
| [Treatment of osteoporosis by risedronate-- speed, efficacy and safety]. | Reumatizam 20060101 |
| Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis. | Yonsei medical journal 20051231 |
| Paget's disease and bisphosphonates. | The New England journal of medicine 20051215 |
| Paget's disease and bisphosphonates. | The New England journal of medicine 20051215 |
| [Optimizing therapy in Paget disease]. | MMW Fortschritte der Medizin 20051215 |
| One drug tackles two diseases. | British dental journal 20051210 |
| Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20051201 |
| Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201 |
| Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty. | International orthopaedics 20051201 |
| High-throughput in vivo screening for bone anabolic compounds with zebrafish. | Journal of biomolecular screening 20051201 |
| Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201 |
| Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201 |
| Prevention and treatment of glucocorticoid-induced osteoporosis in 2005. | Joint, bone, spine : revue du rhumatisme 20051201 |
| Symptomatic hypocalcemia due to oral risedronate therapy. | Indian journal of medical sciences 20051201 |
| The article of Torregrosa JV et al. is virtually identical to the previous publication of Arlen DJ et al. | Transplantation proceedings 20051201 |
| [Examination and treatment of orthopedic-surgery patients with osteoporosis-related fragility fractures]. | Ugeskrift for laeger 20051121 |
| Risedronate therapy for prevention of hip fracture after stroke in elderly women. | Neurology 20051108 |
| Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis. | Clinical rheumatology 20051101 |
| Cyclical alendronate treatment in postmenopausal women with osteoporosis. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20051101 |
| Assessment of a gel-type chelating preparation containing 1-hydroxyethylidene-1, 1-bisphosphonate. | International endodontic journal 20051101 |
| Chelation in root canal therapy reconsidered. | Journal of endodontics 20051101 |
| Bisphosphonate modulates cementoblast behavior in vitro. | Journal of periodontology 20051101 |
| Etidronate ameliorates painful soft-tissue calcification in Werner syndrome. | Journal of the American Geriatrics Society 20051101 |
| [Practical approaches to the osteoporosis treatment--instructions for drug use that draws the effect of the medicine]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Antiresorptive treatment after proximal femur fracture]. | Atencion primaria 20051101 |
| Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051001 |
| Madarosis from mitochondriopathy. | Acta ophthalmologica Scandinavica 20051001 |
| Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial. | Mayo Clinic proceedings 20051001 |
| [Paget's disease of bone]. | Nihon rinsho. Japanese journal of clinical medicine 20051001 |
| Review of treatment modalities for postmenopausal osteoporosis. | Southern medical journal 20051001 |
| Preparation and evaluation of floating risedronate sodium-Gelucire 43/01 formulations. | Drug development and industrial pharmacy 20051001 |
| Profound refractory hypocalcemia after thyroidectomy in a patient receiving chronic oral bisphosphonate therapy. | The American surgeon 20051001 |
| Monitoring of Risedronate by biochemical bone markers in clinical practice. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051001 |
| Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901 |
| Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901 |
| High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. | Bone 20050901 |
| Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. | The New England journal of medicine 20050901 |
| Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy. | Journal of pharmacological sciences 20050901 |
| Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. | Current medical research and opinion 20050901 |
| Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs. | Calcified tissue international 20050901 |
| [Risedronate: a possible treatment for extraosseous calcification]. | Clinical calcium 20050901 |
| Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial. | Climacteric : the journal of the International Menopause Society 20050901 |
| Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability. | International journal of pharmaceutics 20050811 |
| A case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis. | Clinical rheumatology 20050801 |
| Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action. | American journal of physiology. Cell physiology 20050801 |
| Reducing surface tension in endodontic chelator solutions has no effect on their ability to remove calcium from instrumented root canals. | Journal of endodontics 20050801 |
| Alendronate (Fosamax) and risedronate (Actonel) revisited. | Obstetrics and gynecology 20050801 |
| The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. | Archives of internal medicine 20050801 |
| Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. | Archives of internal medicine 20050801 |
| Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis? | Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20050801 |
| The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. | Bone 20050701 |
| Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma. | Bone marrow transplantation 20050701 |
| The use of bisphosphonates in the treatment of osteoporosis. | Current opinion in rheumatology 20050701 |
| X-ray fluorescence methods for investigations of lipid/protein membrane models. | Journal of synchrotron radiation 20050701 |
| Risedronate induced BOOP complicated with sarcoidosis. | Thorax 20050701 |
| Chronic diffuse sclerosing osteomyelitis treated with risedronate. | The Journal of rheumatology 20050701 |
| Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. | Journal of periodontology 20050701 |
| Didronel PMO. | Nursing times 20050701 |
| Efficacy of oral etidronate for skeletal diseases in Japan. | Yonsei medical journal 20050630 |
| Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. | Biochemical pharmacology 20050615 |
| Risedronate in the treatment of Murine Chagas' disease. | Parasitology research 20050601 |
| Potential impact of osteoporosis treatment on hip fracture trends. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050601 |
| Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050601 |
| Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate. | Calcified tissue international 20050601 |
| A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. | Health technology assessment (Winchester, England) 20050601 |
| Microcracks in cortical bone: how do they affect bone biology? | Current osteoporosis reports 20050601 |
| A bright future for osteoporosis treatment. | Drug news & perspectives 20050601 |
| Tiludronate inhibits prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts. | Molecular and cellular endocrinology 20050531 |
| [Marketing--alendronate versus risedronate]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050519 |
| [To increase bone density faster and stronger]. | MMW Fortschritte der Medizin 20050505 |
| Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones? | Spinal cord 20050501 |
| Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. | Rheumatology international 20050501 |
| Current pharmacological treatment for fibrous dysplasia and perspectives for the future. | Joint, bone, spine : revue du rhumatisme 20050501 |
| Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. | European journal of obstetrics, gynecology, and reproductive biology 20050501 |
| Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050501 |
| Alendronate (Fosamax) and risedronate (Actonel) revisited. | The Medical letter on drugs and therapeutics 20050425 |
| [Paget's disease and its therapeutic management]. | Presse medicale (Paris, France : 1983) 20050423 |
| [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates]. | MMW Fortschritte der Medizin 20050407 |
| [Excellent adjustment with greater action. To pay attention to improving compliance]. | MMW Fortschritte der Medizin 20050407 |
| Structural and analytical characterization of three hydrates and an anhydrate form of risedronate. | Journal of pharmaceutical sciences 20050401 |
| [Effects of concurrent therapy for patients with osteoporosis]. | Clinical calcium 20050401 |
| The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancer. | Cancer biotherapy & radiopharmaceuticals 20050401 |
| Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data. | Aging clinical and experimental research 20050401 |
| Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. | Biochemical and biophysical research communications 20050318 |
| Risedronate therapy for prevention of hip fracture after stroke in elderly women. | Neurology 20050308 |
| Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario, Canada. | The Journal of rheumatology 20050301 |
| Oral antiresorptive therapy. | Current rheumatology reports 20050301 |
| Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment. | Bone 20050301 |
| Risedronate for prevention and treatment of osteoporosis in postmenopausal women. | Expert opinion on pharmacotherapy 20050301 |
| [Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050301 |
| Glucocorticoid-induced osteoporosis: treatment options and guidelines. | Current osteoporosis reports 20050301 |
| [Pharmacological treatment of osteitis deformans (Paget's bone disease)]. | Ugeskrift for laeger 20050227 |
| [Evaluation of the effects of treatment of osteoporosis]. | Ugeskrift for laeger 20050227 |
| [Osteoporosis in the elderly--diagnosis and treatment]. | MMW Fortschritte der Medizin 20050217 |
| Alendronate and risedronate: reports of severe bone, joint, and muscle pain. | Archives of internal medicine 20050214 |
| Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050201 |
| Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050201 |
| [Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium]. | Pneumologie (Stuttgart, Germany) 20050201 |
| The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study. | Bone 20050201 |
| Electrolytic deposition of calcium etidronate drug coating on titanium substrate. | Journal of biomedical materials research. Part B, Applied biomaterials 20050115 |
| [FACT study: benefits of alendronate]. | MMW Fortschritte der Medizin 20050113 |
| The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. | Journal of cancer research and clinical oncology 20050101 |
| Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes. | The Annals of pharmacotherapy 20050101 |
| Trochanteric hip fracture in an elderly patient with leprosy during osteoporosis treatment with risedronate and alfacalcidol. | Journal of bone and mineral metabolism 20050101 |
| Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101 |
| Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101 |
| Etidronate and glucocorticoid induced osteoporosis. | The Journal of rheumatology 20050101 |
| Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). | Bone 20050101 |
| Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20050101 |
| The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications. | Oncology 20050101 |
| Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis. | Treatments in endocrinology 20050101 |
| Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis. | Archives of gerontology and geriatrics 20050101 |
| Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro. | Anticancer research 20050101 |
| Effect of adminitration of etidronate and retinol on bone mechanical properties in ovariectomized rats. | Pharmacological reports : PR 20050101 |
| Chondrosarcoma in Paget's disease of bone. | Clinical and experimental rheumatology 20050101 |
| Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. | Arthritis research & therapy 20050101 |
| Heterotopic ossification in bilateral knee and hip joints after long-term sedation. | Journal of bone and mineral metabolism 20050101 |
| Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis. | Treatments in endocrinology 20050101 |
| Systemic effects of fluticasone nasal spray: report of 2 cases. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101 |
| Effects of risedronate on femoral bone mineral density and bone strength in sciatic neurectomized young rats. | Journal of bone and mineral metabolism 20050101 |
| Periodontal assessment of postmenopausal women receiving risedronate. | Menopause (New York, N.Y.) 20050101 |
| Uncommon localization of calcinosis cutis after liver transplantation. | Dermatology (Basel, Switzerland) 20050101 |
| Systemic radionuclide therapy in pain palliation. | The American journal of hospice & palliative care 20050101 |
| Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101 |
| [What do we need to know--what can we do?]. | Krankenpflege Journal 20050101 |
| Seven years of treatment with risedronate in women with postmenopausal osteoporosis. | Calcified tissue international 20041201 |
| Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. | Calcified tissue international 20041201 |
| Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information. | Journal of clinical pharmacy and therapeutics 20041201 |
| [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20041201 |
| Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis. | Current medical research and opinion 20041201 |
| Oral antiresorptive therapy. | Current osteoporosis reports 20041201 |
| Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20041101 |
| Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. | Journal of the American Geriatrics Society 20041101 |
| Pharmacological interventions for treating acute heterotopic ossification. | The Cochrane database of systematic reviews 20041018 |
| Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. | The American journal of medicine 20041015 |
| Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20041001 |
| Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices? | The Journal of rheumatology 20041001 |
| Pharmacologic prevention of osteoporotic fractures. | American family physician 20041001 |
| Treating osteoporosis in post-menopausal women: a case approach. | Cleveland Clinic journal of medicine 20041001 |
| Effects of dimephosphone, xydiphone, and ionol on the content and activities of rat liver cytochromes P-450 during long-term treatment with phenobarbital. | Bulletin of experimental biology and medicine 20041001 |
| New treatments for brittle bones. | Annals of internal medicine 20040907 |
| Coming to grips with bone loss. | Science (New York, N.Y.) 20040903 |
| Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. | Calcified tissue international 20040901 |
| Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040901 |
| Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. | Thorax 20040901 |
| Fracture protection in osteoporosis with risedronate. | Hospital medicine (London, England : 1998) 20040901 |
| Sophie's bones: a case study in osteoporosis. | Advance for nurse practitioners 20040901 |
| [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show]. | Praxis 20040901 |
| Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20040901 |
| Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices. | Acta pharmaceutica (Zagreb, Croatia) 20040901 |
| [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention]. | MMW Fortschritte der Medizin 20040805 |
| [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. | MMW Fortschritte der Medizin 20040805 |
| Osteoblast proliferation and maturation by bisphosphonates. | Biomaterials 20040801 |
| The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. | Bone 20040801 |
| Effects of risedronate on bone density in anorexia nervosa. | The Journal of clinical endocrinology and metabolism 20040801 |
| Monostotic Paget's disease of the tibia in Korea. | Clinical rheumatology 20040801 |
| Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer. | Current oncology reports 20040701 |
| Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty. | Bone 20040701 |
| 186Re-HEDP for metastatic bone pain in breast cancer patients. | European journal of nuclear medicine and molecular imaging 20040601 |
| Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. | Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20040601 |
| Effects of ethane-1-hydroxy-1,1-diphosphonate on ossification of the posterior longitudinal ligament in Zucker fatty rats. | Journal of orthopaedic surgery (Hong Kong) 20040601 |
| Prevention of glucocorticoid-induced osteoporosis. | Southern medical journal 20040601 |
| Effect of etidronate on intraosseous meningioma. | Endocrine journal 20040601 |
| Prevention of trabecular bone loss in the mandible of ovariectomized rats. | Journal of oral science 20040601 |
| [Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient]. | MMW Fortschritte der Medizin 20040527 |
| [Risedronate affects bone strength, too. Faster protective effect on microarchitecture]. | MMW Fortschritte der Medizin 20040527 |
| Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats. | Life sciences 20040521 |
| [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?]. | MMW Fortschritte der Medizin 20040520 |
| Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate. | Journal of gastroenterology and hepatology 20040501 |
| Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040501 |
| Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. | Current medical research and opinion 20040501 |
| Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells. | International journal of hematology 20040501 |
| [Bone quality in treatment with raroxifene ]. | Clinical calcium 20040501 |
| Beneficial effect of etidronate therapy in immobilized hip fracture patients. | American journal of physical medicine & rehabilitation 20040401 |
| Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. | Bone 20040401 |
| Efficacy of risedronate on clinical vertebral fractures within six months. | Current medical research and opinion 20040401 |
| Differential effect of short-term etidronate treatment on three cancellous bone sites in orchidectomized adult rats. | The Keio journal of medicine 20040301 |
| Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. | International journal of antimicrobial agents 20040301 |
| Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. | International journal of antimicrobial agents 20040301 |
| [Data comparison of osteoporosis patients demonstrates nasal administration is not optimal]. | MMW Fortschritte der Medizin 20040212 |
| Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. | Calcified tissue international 20040201 |
| An update on bisphosphonates. | Current rheumatology reports 20040201 |
| Heterotopic ossification in the knee following encephalitis: a case report with a 10-year follow-up. | The Knee 20040201 |
| Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040201 |
| Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20040201 |
| [Bone mass measurement and evaluation of therapeutical response]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [AOS-100]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [New guideline for the treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Treatment of osteoporosis with etidronate]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Risedronate treatment for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Treatment of osteoporosis combined with a bisphosphonate and vitamin D3]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Concurrent treatment of osteoporosis with bisphosphonate and vitamin K2]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Combination therapy of bisphosphonate and estrogen for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases. | The Journal of rheumatology 20040101 |
| Hypercalcemia in patients with disseminated coccidioidomycosis. | The American journal of the medical sciences 20040101 |
| The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. | Alcoholism, clinical and experimental research 20040101 |
| Adult-onset idiopathic progressive acro-osteolysis with proximal symphalangism. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040101 |
| Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies. | Journal of bone and mineral metabolism 20040101 |
| Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption. | Journal of bone and mineral metabolism 20040101 |
| Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis. | Journal of bone and mineral metabolism 20040101 |
| Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database. | Journal of managed care pharmacy : JMCP 20040101 |
| Parathyroid hormone. | The Journal of the American Academy of Orthopaedic Surgeons 20040101 |
| Effect of etidronate on three-dimensional trabecular structure in ovariectomized or sciatic neurectomized rats. | Journal of bone and mineral metabolism 20040101 |
| Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study. | European review for medical and pharmacological sciences 20040101 |
| Markers of bone resorption in bisphosphonate therapy of Paget's disease. | Clinical and experimental rheumatology 20040101 |
| [Consistent therapeutic success in osteoporosis]. | Krankenpflege Journal 20040101 |
| Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. | Journal of bone and mineral metabolism 20040101 |
| A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. | Journal of bone and mineral metabolism 20040101 |
| Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20040101 |
| Prevention and treatment of heterotopic ossification after spinal cord injury. | The journal of spinal cord medicine 20040101 |
| Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations. | MedGenMed : Medscape general medicine 20040101 |
| Health-economic comparison of three recommended drugs for the treatment of osteoporosis. | International journal of clinical pharmacology research 20040101 |
| C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. | The journal of spinal cord medicine 20040101 |
| [Update 2004. Osteoporosis--management--current status]. | Krankenpflege Journal 20040101 |
| [Routine osteoporosis therapy]. | Krankenpflege Journal 20040101 |
| Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study. | International journal of clinical pharmacology research 20040101 |
| Effect of administration of retinol and etidronate on bone histomorphometric parameters in ovariectomized rats. | Acta poloniae pharmaceutica 20040101 |
| An immunohistochemical evaluation of extracellular matrix components in the spinal posterior longitudinal ligament and intervertebral disc of the tiptoe walking mouse. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20040101 |
| Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. | Endocrinology 20031201 |
| Compliance with pharmacologic therapy for osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201 |
| Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201 |
| Preparation of 1-hydroxyethylidene-1,1-diphosphonic acid-intercalated layered double hydroxide and its physicochemical properties. | Journal of pharmaceutical sciences 20031201 |
| Spectrophotometric determination of some drugs for osteoporosis. | Chemical & pharmaceutical bulletin 20031201 |
| A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031201 |
| Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. | Bone 20031201 |
| Patent news. | IDrugs : the investigational drugs journal 20031201 |
| Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup. | The Journal of rheumatology 20031201 |
| Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures. | The Keio journal of medicine 20031201 |
| Myeloprotective effects of different amifostine regimens in rabbits undergoing high-dose treatment with 186rhenium-(tin)1,1- hydroxyethylidene diphosphonate (186Re-HEDP). | Cancer biotherapy & radiopharmaceuticals 20031201 |
| An approach to postmenopausal osteoporosis treatment: a case study review. | Journal of the American Academy of Nurse Practitioners 20031201 |
| Osteoporosis management in the new millennium. | Primary care 20031201 |
| Use of highly potent bisphosphonates in the treatment of osteoporosis. | Current osteoporosis reports 20031201 |
| Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases. | Journal of experimental & clinical cancer research : CR 20031201 |
| Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography. | Calcified tissue international 20031101 |
| Aging bone and osteoporosis: strategies for preventing fractures in the elderly. | Archives of internal medicine 20031013 |
| Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031001 |
| Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. | The American journal of gastroenterology 20031001 |
| [Beneficial effect of high-dose etidronate on periarticular calcinosis associated with arterial and periarticular basic calcium phosphate (BCP) crystal deposition disease]. | Ryumachi. [Rheumatism] 20031001 |
| Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. | Cancer biotherapy & radiopharmaceuticals 20031001 |
| First synthesis of etidronate partial amides starting from PCl3. | Organic & biomolecular chemistry 20030921 |
| Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation. | Clinical nuclear medicine 20030901 |
| Mechanism of action of bisphosphonates. | Current osteoporosis reports 20030901 |
| Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825 |
| Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. | British journal of cancer 20030818 |
| A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. | European journal of nuclear medicine and molecular imaging 20030801 |
| Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801 |
| Two cases of monostotic Paget's disease: effects of bisphosphonate. | Endocrine journal 20030801 |
| [Evidence-based therapy of osteoporosis--comment on DMW 17/2003]. | Deutsche medizinische Wochenschrift (1946) 20030725 |
| Bisphosphonates: new indications and methods of administration. | Current opinion in rheumatology 20030701 |
| Show us the numbers. | Canadian family physician Medecin de famille canadien 20030701 |
| Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty. | Bone 20030701 |
| Therapeutic efficiency of dimephosphone and xydiphone in experimental pulse therapy with prednisolone. | Bulletin of experimental biology and medicine 20030701 |
| Biochemical characterization of the serum fetuin-mineral complex. | The Journal of biological chemistry 20030613 |
| The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. | The Journal of biological chemistry 20030613 |
| [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years]. | MMW Fortschritte der Medizin 20030605 |
| Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030601 |
| Identifying the osteopenic patient and preventing worsening of the disease. | Current women's health reports 20030601 |
| Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. | Archives of gynecology and obstetrics 20030601 |
| Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030601 |
| Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030601 |
| Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis. | The Keio journal of medicine 20030601 |
| [Effects of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the formation of dental hard tissue of mouse molar tooth germs in organ culture system]. | Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan 20030601 |
| Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. | Calcified tissue international 20030601 |
| [To treat effectively without delay. The data on fractures decisive]. | MMW Fortschritte der Medizin 20030522 |
| [For patients with osteoporosis-induced fracture the emergency brake must be pulled. Every 4th patient as a recurrence in the following year]. | MMW Fortschritte der Medizin 20030508 |
| Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis. | European journal of endocrinology 20030501 |
| Tolerability and compliance with risedronate in clinical practice. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501 |
| A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501 |
| A case of dizziness, headache, aural fullness, and concentration difficulty following scuba diving. | Ear, nose, & throat journal 20030501 |
| [Osteoporosis in men]. | Deutsche medizinische Wochenschrift (1946) 20030425 |
| Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts. | Bone 20030401 |
| Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women. | Canadian family physician Medecin de famille canadien 20030401 |
| [Osteoporosis therapy. Bisphosphonates compared]. | MMW Fortschritte der Medizin 20030327 |
| Capillary electrophoretic and thin-layer chromatographic characterization of rhenium complexation with 1-hydroxyethylidenediphosphonic acid. | Journal of chromatography. A 20030321 |
| Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture. | Calcified tissue international 20030301 |
| Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. | The Journal of rheumatology 20030301 |
| Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. | The Journal of rheumatology 20030301 |
| EANM procedure guidelines for treatment of refractory metastatic bone pain. | European journal of nuclear medicine and molecular imaging 20030301 |
| Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats. | Chronobiology international 20030301 |
| [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it]. | MMW Fortschritte der Medizin 20030220 |
| Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro. | Calcified tissue international 20030201 |
| Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030201 |
| Editorial: greater risk, greater benefit--true or false? | The Journal of clinical endocrinology and metabolism 20030201 |
| Risedronate prevents new vertebral fractures in postmenopausal women at high risk. | The Journal of clinical endocrinology and metabolism 20030201 |
| Three hydrates of the bisphosphonate risedronate, consisting of one molecular and two ionic structures. | Acta crystallographica. Section C, Crystal structure communications 20030201 |
| Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. | Bone 20030201 |
| [Effects of bisphosphonate on trabecular microstructure]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Etidronate]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Risedronate]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Treatment of osteoporosis provided from the orthopaedic surgeon's standpoint]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. | Digestive diseases and sciences 20030201 |
| [Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective]. | Lakartidningen 20030109 |
| [Psychiatric side effects associated with diphosphonate treatment]. | Nederlands tijdschrift voor geneeskunde 20030104 |
| A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids. | The Journal of rheumatology 20030101 |
| Bone density changes with once weekly risedronate in postmenopausal women. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101 |
| Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20030101 |
| Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases. | Clinical and experimental rheumatology 20030101 |
| [Effect of dimephosphon and xydiphone on mineral metabolism and lipid peroxidation in rats subjected to 'pulse-therapy' with prednisolone]. | Eksperimental'naia i klinicheskaia farmakologiia 20030101 |
| [Prophylaxis of the unfavorable shifts in mineral turnover in bones during extended exposure to the conditions reproducing the physiological effects of microgravity]. | Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20030101 |
| Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy. | Journal of bone and mineral metabolism 20030101 |
| Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis. | International journal of fertility and women's medicine 20030101 |
| Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20030101 |
| Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. | Current medical research and opinion 20030101 |
| Risedronate for the prevention and treatment of postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20030101 |
| Application of rhenium-188 HEDP in bone metastases therapy. | Nuclear medicine review. Central & Eastern Europe 20030101 |
| Suppression of alveolar bone resorption by etidronate treatment for periodontal disease: 4- to 5-year follow-up of four patients. | The Journal of international medical research 20030101 |
| What predicts early fracture or bone loss on bisphosphonate therapy? | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101 |
| [Bisphosphonates in the prevention of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis]. | Reumatizam 20030101 |
| Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. | Advances in experimental medicine and biology 20030101 |
| Pharmacoeconomic analysis of osteoporosis treatment with risedronate. | International journal of clinical pharmacology research 20030101 |
| Risedronate once a week. | Treatments in endocrinology 20030101 |
| A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20021201 |
| Medications for postmenopausal osteoporosis prevention. | Harvard women's health watch 20021201 |
| Risedronate prevents hip fractures, but who should get therapy? | Cleveland Clinic journal of medicine 20021201 |
| Treatment of hypercalcemia of malignancy with bisphosphonates. | Seminars in oncology 20021201 |
| [Osteoporosis]. | Der Internist 20021201 |
| Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. | Cancer research 20021115 |
| Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up. | Pediatric pulmonology 20021101 |
| Bisphosphonate induces remission of refractory osteolysis in langerhans cell histiocytosis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021101 |
| Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. | Bone 20021101 |
| [Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate]. | MMW Fortschritte der Medizin 20021031 |
| Once-a-week risedronate (actonel). | The Medical letter on drugs and therapeutics 20021014 |
| Bisphosphonates and the upper gastrointestinal tract: skeletal gain without visceral pain? | Mayo Clinic proceedings 20021001 |
| The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women. | Canadian journal of physiology and pharmacology 20021001 |
| Ca-binding domains in the odontoblast layer of rat molars and incisors under normal and pathological conditions. | Archives of histology and cytology 20021001 |
| [Treatment of osteoporosis. Not only measurements count]. | MMW Fortschritte der Medizin 20020905 |
| The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020901 |
| 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. | The Journal of rheumatology 20020901 |
| Bisphosphonates. | Maturitas 20020830 |
| Commentary on: Bone mineral density and fracture prevalence in long-term kidney graft recipients. | Transplantation 20020827 |
| The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. | Calcified tissue international 20020801 |
| Management of immature heterotopic ossification (HO) of the hip. | Spinal cord 20020801 |
| Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020801 |
| Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020801 |
| What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. | Digestive diseases and sciences 20020801 |
| Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. | Endocrine reviews 20020801 |
| [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis]. | Ryumachi. [Rheumatism] 20020801 |
| Osteoporosis in elderly: prevention and treatment. | Clinics in geriatric medicine 20020801 |
| [Osteoporosis therapy. A comparison of bisphosphonates]. | MMW Fortschritte der Medizin 20020711 |
| Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. | Endocrinology 20020701 |
| Neurogenic heterotopic ossification in spinal cord injury. | Spinal cord 20020701 |
| Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701 |
| Bone quality: getting closer to a definition. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701 |
| Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701 |
| Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. | Journal of periodontology 20020701 |
| Etidronate influences growth and phenotype of rat vascular smooth muscle cells. | Pharmacological research 20020701 |
| High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. | British journal of cancer 20020605 |
| Beneficial effect of etidronate on bone loss after cessation of exercise in postmenopausal osteoporotic women. | American journal of physical medicine & rehabilitation 20020601 |
| Bisphosphonate prodrugs. | Current medicinal chemistry 20020601 |
| On the origin of intrinsic matrix of acellular extrinsic fiber cementum: studies on growing cementum pearls of normal and bisphosphonate-affected guinea pig molars. | European journal of oral sciences 20020601 |
| [Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA)]. | Ultraschall in der Medizin (Stuttgart, Germany : 1980) 20020601 |
| Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study. | Regulatory toxicology and pharmacology : RTP 20020601 |
| Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020528 |
| Treatment and follow-up of pulmonary alveolar microlithiasis with disodium editronate: radiological demonstration. | Pediatric radiology 20020501 |
| The cost utility of bisphosphonate treatment in established osteoporosis. | QJM : monthly journal of the Association of Physicians 20020501 |
| Lymphoplasmacytoid lymphoma presenting as severe osteoporosis. | American journal of hematology 20020501 |
| Risedronate: a new oral bisphosphonate. | Clinical therapeutics 20020501 |
| [Episcleritis secondary to risedronate]. | Medicina clinica 20020427 |
| [When osteoporosis first manifests itself. Without therapy the next fracture threatens]. | MMW Fortschritte der Medizin 20020404 |
| Risedronate for the prevention of fractures in postmenopausal osteoporosis. | The Annals of pharmacotherapy 20020401 |
| [Risedronate, a new diphosphonate in osteoporosis and Paget's disease]. | Presse medicale (Paris, France : 1983) 20020302 |
| Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials. | Mayo Clinic proceedings 20020301 |
| Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis. | The Annals of pharmacotherapy 20020301 |
| COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy. | Calcified tissue international 20020301 |
| [Advancement of treatment for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| [Comparative analyses on osteoporosis guidelines in Japan, EU and USA]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| [Bisphosphonates: pharmacology and use in the treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| [Risedronate: clinical usage]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| Physicians' liability and drug formulary restrictions. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020219 |
| Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. | The Journal of biological chemistry 20020208 |
| Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. | Bone 20020201 |
| Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. | Breast cancer research and treatment 20020201 |
| A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy. | Gerontology 20020101 |
| The underuse of therapy in the secondary prevention of hip fractures. | Drugs & aging 20020101 |
| A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats. | Journal of physiological anthropology and applied human science 20020101 |
| [Pathogenetic validation of xidiphone use in combined therapy for periodontal diseases]. | Stomatologiia 20020101 |
| Bisphosphonates for the relief of pain secondary to bone metastases. | The Cochrane database of systematic reviews 20020101 |
| Risedronate reduces the risk of first vertebral fracture in osteoporotic women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020101 |
| [Effect of dimephosphon and xidifon on parameters of lipid peroxidation and the antioxidant system in rats subjected to the long-term administration of prednisolone]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
| Response of bone mineral density to once-weekly administration of risedronate. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101 |
| Transient relief of metastatic cancer bone pain by oral administration of etidronate. | Journal of bone and mineral metabolism 20020101 |
| Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity. | Reviews in gastroenterological disorders 20020101 |
| Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review. | Drug safety 20020101 |
| A review of combination regimens for osteoporosis--prevention and treatment. | International journal of fertility and women's medicine 20020101 |
| [Osteoporosis: diagnosis, prevention and treatment]. | Medicina (Kaunas, Lithuania) 20020101 |
| [Osteoporosis: diagnosis and treatment of vertebral fractures]. | Medicina (Kaunas, Lithuania) 20020101 |
| Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20020101 |
| [Comparative study of the effect of dimephosphon monophosphonate and xydiphone biphosphonate on the histomorphometric indices of rat vertebra in a model of glucocorticosteroid osteoporosis]. | Eksperimental'naia i klinicheskaia farmakologiia 20020101 |
| Prevention and treatment of osteoporosis. | Clinical cornerstone 20020101 |
| [Therapy of osteoporosis. Risk factors alone are not an indication]. | MMW Fortschritte der Medizin 20011206 |
| Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. | Bone 20011201 |
| Review of risedronate in the treatment of osteoporosis. | Expert opinion on pharmacotherapy 20011201 |
| Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201 |
| Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201 |
| [Economic aspects of osteoporosis therapy. What does a prevented fracture cost?]. | MMW Fortschritte der Medizin 20011122 |
| A method to assess the proportion of treatment effect explained by a surrogate endpoint. | Statistics in medicine 20011115 |
| Rhenium-188 HEDP to treat painful bone metastases. | Clinical nuclear medicine 20011101 |
| Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011101 |
| Role of alendronate and risedronate in preventing and treating osteoporosis. | Cleveland Clinic journal of medicine 20011101 |
| Familial fibrodysplasia ossificans progressiva: trial with etidronate disodium. | Indian pediatrics 20011101 |
| Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. | Calcified tissue international 20011101 |
| [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates]. | Gynecologie, obstetrique & fertilite 20011101 |
| [Osteoporosis. Fracture as alarm signal]. | MMW Fortschritte der Medizin 20011011 |
| Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study. | Radiology 20011001 |
| Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. | Bone 20011001 |
| Low-dose oral etidronate therapy for immobilization hypercalcaemia associated with Guillain-Barré syndrome. | Acta paediatrica (Oslo, Norway : 1992) 20011001 |
| Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy. | Joint, bone, spine : revue du rhumatisme 20011001 |
| Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. | Calcified tissue international 20011001 |
| Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates. | Calcified tissue international 20011001 |
| Tolerability of risedronate in postmenopausal women intolerant of alendronate. | Aging (Milan, Italy) 20011001 |
| [Giant esophageal ulcer probably due to etidronate]. | Gastroenterologie clinique et biologique 20011001 |
| Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. | The Journal of biological chemistry 20010907 |
| [Optimizing treatment of osteoporosis. Rapidly effective therapy lowers fracture risk in 1 year up to 70%]. | MMW Fortschritte der Medizin 20010906 |
| [Risedronate now also approved for hip fractures. Study discloses significant risk reduction in proximal femoral neck fractures]. | MMW Fortschritte der Medizin 20010906 |
| Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates. | Blood 20010901 |
| Pharmacologic therapy for the treatment and prevention of osteoporosis. | The Nursing clinics of North America 20010901 |
| Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures. | Bone 20010901 |
| The diagnosis of Paget's disease. | The Practitioner 20010901 |
| Bisphosphonates for osteoporosis. | Drug and therapeutics bulletin 20010901 |
| Risedronate: a new oral bisphosphonate. | Clinical therapeutics 20010901 |
| Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature. | Obstetrical & gynecological survey 20010801 |
| 186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation. | Nuclear medicine and biology 20010801 |
| The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans. | International journal of pharmaceutics 20010717 |
| The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. | International journal of pharmaceutics 20010717 |
| [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures]. | Nederlands tijdschrift voor geneeskunde 20010714 |
| A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. | European journal of nuclear medicine 20010701 |
| [Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. | La Revue de medecine interne 20010701 |
| [Fluorides and bisphosphonates in the treatment of osteoporosis]. | Der Orthopade 20010701 |
| (31)P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth. | Biochemical and biophysical research communications 20010615 |
| Osteoporosis in men. | American family physician 20010615 |
| Re: Lanza et al.--Endoscopic comparison of alendronate and risedronate. | The American journal of gastroenterology 20010601 |
| Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. | The American journal of managed care 20010601 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| Absolute vs. relative numbers in evaluating drug therapy. | American family physician 20010515 |
| [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture]. | MMW Fortschritte der Medizin 20010503 |
| The role of combination treatment for osteoporosis. | The Journal of clinical endocrinology and metabolism 20010501 |
| Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. | The Journal of clinical endocrinology and metabolism 20010501 |
| Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. | Arteriosclerosis, thrombosis, and vascular biology 20010501 |
| Management of male osteoporosis. | Joint, bone, spine : revue du rhumatisme 20010501 |
| Risedronate: clinical usage. | International journal of clinical practice 20010501 |
| Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate. | Japanese journal of pharmacology 20010501 |
| Analgesic effect of bisphosphonates in mice. | Pain 20010401 |
| Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000. | Clinical therapeutics 20010401 |
| Once-a-week alendronate (Fosamax). | The Medical letter on drugs and therapeutics 20010319 |
| Treatment of established bone loss after renal transplantation with etidronate. | Transplantation 20010315 |
| Prevention of secondary osteoporosis postmenopause in hemiplegia. | American journal of physical medicine & rehabilitation 20010301 |
| Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats. | Bone 20010301 |
| Hip fractures: do preventive drugs work for all? | Health news (Waltham, Mass.) 20010301 |
| Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010301 |
| Evidence-based medicine: putting theory into practice. | Hospital medicine (London, England : 1998) 20010301 |
| Response of cortical bone to antiresorptive treatment. | Calcified tissue international 20010301 |
| Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. | Breast cancer research and treatment 20010301 |
| Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. | The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 20010301 |
| 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases. | The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 20010301 |
| Risedronate: a clinical review. | Archives of internal medicine 20010212 |
| Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. | The New England journal of medicine 20010201 |
| Ulcerative esophagitis caused by etidronate. | Gastrointestinal endoscopy 20010201 |
| Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010201 |
| Treatment of osteoporosis with bisphosphonates. | Rheumatic diseases clinics of North America 20010201 |
| Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. | Pharmaceutical research 20010201 |
| Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects. | Alimentary pharmacology & therapeutics 20010101 |
| Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis. | Bone 20010101 |
| A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20010101 |
| Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women. | Clinical and experimental rheumatology 20010101 |
| Prevention and treatment of osteoporosis. | Clinical medicine (London, England) 20010101 |
| Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease. | Drugs 20010101 |
| Analgesic effect of etidronate on degenerative joint disease. | Journal of bone and mineral metabolism 20010101 |
| Effect of intermittent cyclical treatment with etidronate disodium (HEBP) and calcium plus alphacalcidol in postmenopausal osteoporosis. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20010101 |
| Clinical effect of etidronate on alveolar pyorrhoea associated with chronic marginal periodontitis: report of four cases. | The Journal of international medical research 20010101 |
| Etidronate for treating and preventing postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20010101 |
| Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20010101 |
| Risedronate treatment and extended fracture protection in postmenopausal women. | Clinical and experimental rheumatology 20010101 |
| Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20010101 |
| [Balneological use of bath concentrate containing xidifon and essential oils from ginger, nutmeg, and sandal]. | Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20010101 |
| Osteoporosis in men. | Orthopedic nursing 20010101 |
| Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis. | Calcified tissue international 20010101 |
| [Patients with fractures are in the front line for osteoporosis treatment but how to treat?]. | Duodecim; laaketieteellinen aikakauskirja 20010101 |
| Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401 |
| Cauda equina syndrome with pagetic vertebral fusion. Clinical recovery under calcium-vitamin D supplementation plus clodronate after apparent failure of pamidronate and acquired resistance to etidronate. | Revue du rhumatisme (English ed.) 19970101 |
| A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. | Bone 19950801 |
| HPLC separated fractions of 99mTc(NaBH4)-HEDP as myocardial infarct imaging agents. | International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 19860101 |
| The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. | Atherosclerosis 19750101 |
| Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. | The Journal of clinical endocrinology and metabolism |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.